OptiBiotix Health extends manufacturing pact with Sacco

Wed, 11th Mar 2020

Dietry supplements group OptiBiotix Health said subsidiary ProBiotix had signed a new global manufacturing and supply agreement with Sacco. The pact modified and extended an existing relationship between the companies through to the end of 2023. It changed an original profit-sharing agreement to a manufacture and supply agreement, with pricing discounts for increasing sales volumes. 'This allows the company to benefit from a reduced price of goods as sales volumes grow and provide more evenly distributed income throughout the year,' OptiBiotix said. At 9:12am: (LON:OPTI) Optibiotix Health Plc share price was +1p at 43.5p Story provided by StockMarketWire.com

FTSE 100 Latest
Value6,484.30
Change142.86